Target intelligence / Profile preview

RN7SK pseudogene 11 (RN7SKP11)

Target
RN7SKP11
Molecular classification
Other (Pseudogene)
01

Overview

RN7SK pseudogene 11 (RN7SKP11) is classified as a pseudogene, specifically a pseudogenic copy of the 7SK small nuclear RNA gene (RN7SK)[3][5]. Pseudogenes are generally non-functional remnants of genes that have lost their protein-coding ability or are otherwise non-expressed due to mutations. Unlike protein-coding genes or functional non-coding RNAs, pseudogenes like RN7SKP11 are not known to be involved in specific biological processes, do not encode protein or functional RNA, and are not recognized as therapeutic targets, receptors, or enzymes[3][5]. No diseases, functions, interacting drugs, or safety considerations have been associated with RN7SKP11. RN7SKP11 is documented in authoritative gene databases such as GeneCards and NCBI Gene, where it is explicitly categorized as a pseudogene[3][5]. It should not be confused with the functional 7SK small nuclear RNA gene RN7SK, which has established regulatory roles in transcription and cellular processes[1][2][6]. As a pseudogene, RN7SKP11 has no known biological function and is not a therapeutic target. It does not participate in recognized molecular families like receptors, enzymes, or channels[3][5]. No clinical or research literature describes any disease role, drug interaction, biomarker usage, or safety issues specific to RN7SK pseudogene 11[3][5]. RN7SKP11 is a pseudogene and not an active molecular target. No evidence indicates errors in the synonymy or identification of this entry. No evidence supports its role in disease, drug interaction, or therapeutic development.

Other names
RNA, 7SK small nuclear pseudogene 11RN7SKP11

Beyond the preview

Go deeper on RN7SK pseudogene 11 (RN7SKP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 11 (RN7SKP11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call